Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kelly R. Rhodes"'
Autor:
Elana Ben-Akiva, John W. Hickey, Randall A. Meyer, Ariel Isser, Sydney R. Shannon, Natalie K. Livingston, Kelly R. Rhodes, Alyssa K. Kosmides, Tiarra R. Warren, Stephany Y. Tzeng, Jonathan P. Schneck, Jordan J. Green
Publikováno v:
Acta Biomaterialia. 160:187-197
Autor:
Sarah Y. Neshat, Stuart J. Bauer, Kelly R. Rhodes, Victor M. Quiroz, Valerie W. Wong, Shirley M. Lowmaster, Stephany Y. Tzeng, Jordan J. Green, Joshua C. Doloff
Publikováno v:
ACS Biomaterials Science & Engineering.
Publikováno v:
Biomaterials Science. 7:14-30
New advances in biomaterial-based approaches to modulate the immune system are being applied to treat cancer, infectious diseases, and autoimmunity. Particulate systems are especially well-suited to deliver immunomodulatory factors to immune cells si
Autor:
Natalie K. Livingston, John W. Hickey, Randall A. Meyer, Stephany Y. Tzeng, Kelly R. Rhodes, Jonathan P. Schneck, Jordan J. Green, Elana Ben-Akiva, Ariel Isser, Alyssa K. Kosmides
Publikováno v:
ACS Appl Mater Interfaces
Biomimetic biomaterials are being actively explored in the context of cancer immunotherapy because of their ability to directly engage the immune system to generate anti-tumor responses. Unlike cellular therapies, biomaterial-based immunotherapies ca
Publikováno v:
Expert Opin Drug Deliv
INTRODUCTION: Gene delivery technologies are being developed for an increasing number of biomedical applications, with delivery vehicles including viruses and non-viral materials. Among biomaterials used for non-viral gene delivery, poly(beta-amino e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557cb3960d670fee73035962e95c5401
https://europepmc.org/articles/PMC7658038/
https://europepmc.org/articles/PMC7658038/
Publikováno v:
Acta Biomater
Regulatory T cell (Treg)-based therapeutics are receiving increased attention for their potential to treat autoimmune disease and prevent transplant rejection. Adoptively transferred Tregs have shown promise in early clinical trials, but cell-based t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d791cf947a07a3e07fb0da0167745a4f
https://europepmc.org/articles/PMC7365762/
https://europepmc.org/articles/PMC7365762/
Autor:
Kelly R. Rhodes, Jordan J. Green
Publikováno v:
Molecular Immunology. 98:13-18
Exciting developments in cancer nanomedicine include the engineering of nanocarriers to deliver drugs locally to tumors, increasing efficacy and reducing off-target toxicity associated with chemotherapies. Despite nanocarrier advances, metastatic can
Autor:
Randall A. Meyer, Kelly R. Rhodes, Martin G. Pomper, Jordan J. Green, Keyvan Farahani, Nicholas Ellens, Raag D. Airan, Shilpa D. Kadam
Publikováno v:
Nano Letters
Targeted, noninvasive neuromodulation of the brain of an otherwise awake subject could revolutionize both basic and clinical neuroscience. Toward this goal, we have developed nanoparticles that allow noninvasive uncaging of a neuromodulatory drug, in
Autor:
Rohan Fernandes, Jesse K. Placone, Helim Aranda-Espinoza, Che-Ying Kuo, Avinash Eranki, Kelly R. Rhodes, Peter C.W. Kim, John P. Fisher
Publikováno v:
ACS Biomaterials Science & Engineering. 2:1817-1826
Preeclampsia (PE) is a leading cause of maternal and perinatal morbidity and mortality. Current research suggests that the impaired trophoblastic invasion of maternal spiral arteries contributes significantly to the development of PE. However, the pa
Publikováno v:
BMC Immunology
Background Ebola is a Filovirus (FV) that induces a highly communicable and deadly hemorrhagic fever. Currently, there are no approved vaccines to treat FV infections. Protection from FV infection requires cell mediated and humoral immunity. Glycopro